TORONTO--(BUSINESS WIRE)--
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the Natixis Bleichroeder 2nd Annual Hidden Gems Conference at The Waldorf=Astoria hotel in New York City.
Biovail's presentation is scheduled for Monday, October 13, 2008 at 2 p.m. EDT. A live and archived Webcast will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
